Literature DB >> 20535106

Pandemic influenza preparedness and response in Israel: a unique model of civilian-defense collaboration.

Sivan Kohn1, Daniel J Barnett, Alex Leventhal, Shmuel Reznikovich, Meir Oren, Danny Laor, Itamar Grotto, Ran D Balicer.   

Abstract

In April 2009, the World Health Organization announced the emergence of a novel influenza A(H1N1-09) virus and in June 2009 declared the outbreak a pandemic. The value of military structures in responding to pandemic influenza has become widely acknowledged in recent years. In 2005, the Israeli Government appointed the Ministry of Defense to be in charge of national preparedness and response for a severe pandemic influenza scenario. The Israeli case offers a unique example of civilian-defense partnership where the interface between the governmental, military and civilian spheres has formed a distinctive structure. The Israeli pandemic preparedness protocols represent an example of a collaboration in which aspects of an inherently medical problem can be managed by the defense sector. Although distinctive concepts of the model are not applicable to all countries, it offers a unique forum for governments and international agencies to evaluate this interface within the context of pandemic influenza.

Entities:  

Mesh:

Year:  2010        PMID: 20535106     DOI: 10.1057/jphp.2010.17

Source DB:  PubMed          Journal:  J Public Health Policy        ISSN: 0197-5897            Impact factor:   2.222


  2 in total

Review 1.  Civil-military cooperation in the management of infectious disease outbreaks: a scoping review.

Authors:  Jacobine Janse; Jori Pascal Kalkman; George Louis Burchell; Adriaan Pieter Cornelis Christiaan Hopperus Buma; Teun Zuiderent-Jerak; Myriame Thérèse Isabella Beatrice Bollen; Aura Timen
Journal:  BMJ Glob Health       Date:  2022-06

2.  Public health preparedness and response in the USA since 9/11: a national health security imperative.

Authors:  Ali S Khan
Journal:  Lancet       Date:  2011-09-03       Impact factor: 79.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.